Yoshiharu Miyata

NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia

Seiji Kakiuchi, Yosuke Minami, Yoshiharu Miyata et al. · International Journal of Molecular Sciences · 2017 · 21 citations · Full text

Medicine, Cell Biology, Oncology +17

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi et al. · Vaccines · 2022 · 21 citations · Full text

Veterinary Medicine, Hematology, Immunology +8

An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells

Yu Mizutani, Aki Inase, Yimamu Maimaitili et al. · International Journal of Hematology · 2019 · 20 citations

Life Sciences, Oncology, Pharmacology +16

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi et al. · Vaccines · 2022 · 20 citations · Full text

Veterinary Medicine, Immunology, Immunization +13

Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation

Yumiko Inui, Kimikazu Yakushijin, Atsuo Okamura et al. · Transplant Infectious Disease · 2018 · 19 citations · Full text

Medicine, Hematology, Infectious Diseases +14